Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
REGEnLIFE cures inflammatory brain diseases with light
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups

Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation

15th Clinical Trials on Alzheimer’s Disease (CTAD) 2022, San Francisco
CTAD 2023

Julien Delrieu, Aroa Relano-Gines, Patrice Cristofini, Julie Bisiaux, Sara Guillemin, Guillaume Blivet, Jacques Touchon

Share this article